ROYAL BANK OF CANADA - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 162 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$222,000
+54.2%
10,813
+49.5%
0.00%
Q2 2023$144,000
-92.0%
7,234
-93.1%
0.00%
Q1 2023$1,795,000
+784.2%
104,765
+909.0%
0.00%
Q4 2022$203,000
+2155.6%
10,383
+1848.0%
0.00%
Q3 2022$9,000
-96.5%
533
-97.2%
0.00%
Q2 2022$259,000
+547.5%
18,829
+643.3%
0.00%
Q1 2022$40,000
-79.5%
2,533
-71.7%
0.00%
Q4 2021$195,000
+91.2%
8,941
+162.3%
0.00%
Q3 2021$102,000
-15.0%
3,409
+25.3%
0.00%
Q2 2021$120,000
-92.5%
2,720
-92.4%
0.00%
Q1 2021$1,592,000
+19800.0%
35,886
+26286.8%
0.00%
Q4 2020$8,000
+300.0%
136
-9.3%
0.00%
Q1 2020$2,000
-92.3%
150
-86.7%
0.00%
Q4 2019$26,000
+62.5%
1,124
+77.0%
0.00%
Q3 2018$16,000
-52.9%
635
-63.5%
0.00%
Q2 2018$34,000
-24.4%
1,741
-27.3%
0.00%
Q1 2018$45,0002,3940.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$9,851,00011.04%
RTW INVESTMENTS, LP 15,802,802$217,447,0005.62%
Amitell Capital Pte Ltd 97,331$1,339,0003.05%
Prosight Management, LP 276,802$3,809,0003.00%
TANG CAPITAL MANAGEMENT LLC 1,265,900$17,419,0002.64%
Affinity Asset Advisors, LLC 250,466$3,446,0001.45%
COWEN AND COMPANY, LLC 1,000,000$13,760,0001.33%
Boxer Capital, LLC 1,466,051$20,173,0001.28%
Cormorant Asset Management, LP 868,550$11,951,0000.90%
MAVERICK CAPITAL LTD 2,532,366$34,845,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders